Unstable angina: diltiazem was probably as good as propranolol in reducing angina attacks.
|
|
|
Clinical bottom line (level 1b-)
-
In patients with unstable angina, diltiazem may be as effective as propranolol in reducing angina attacks.
|
|
Andre-Fouet et al:
European Heart Journal
1983;
4:
691-698
|
Expires
June 2003
|
The study
Unblinded concealed randomised
trial
with
intention-to-treat
Setting: coronary care unit, acute hospital, France
70 patients
(aged
range 39 to 83 years; mean 60,
87%
male)
unstable angina, defined as :
- appearance of new onset angina
- aggravation less than one month previously of angina
Excluded if
- MI within one month
- contraindication to beta-blockers
- treatment during previous months with amiodarone or perhexiline
- atrial fibrillation or flutter, sinus bradycardia or AV block
- congestive heart failure, aortic valvular disease
- anaemia (Hb <10 g/dl), current thyroid disease, renal or hepatic failure
Control Group: (n = 36, 36 analysed):
propranolol
40 mg twice daily po. Dose was increased until anginal attacks disappeared or 360 mg per day was reached
Experimental Group: (n = 34, 34 analysed):
diltiazem
60 to 120 mg twice daily po. Dose was increased until anginal attacks disappeared or 540 mg per day was reached.
Patients were treated with heparin, oral antidiabetics, diuretics, sublingual nitroglycerin, analgesia and sedatives as required. Use of long acting nitrates was not permitted. All patients had intermittent infusions of heparin (3000 to 5000 units every three hours). All anti-anginal medication was stopped until ECG changes were recorded during spontaneous chest pain.
100% followed for
1-10
days
The evidence
| Outcome |
Time to outcome |
CER | EER | RRR (95% CI) | ARR (95% CI) | NNT (95% CI) |
| continuation of angina attacks
|
1-10
days |
18 (50.0%) |
11 (32.4%) |
35% (-16% to
64%) |
17.7% (-5.03% to
40.3%) |
6
(NNT = 2 to infinity;
NNH =
20
to infinity)
|
Comments
- Management of unstable angina has changed since this study- patients are now routinely given aspirin and continuous heparin. Medication is usually continued and not stopped on admission.
- Short follow-up and small numbers mean that diltiazem may be potentially more harmful than propranolol. Other studies have shown that diltiazem has no effect on reducing mortality unlike beta-blockers.
Citation
-
Andre-Fouet
X,
Usdin
JP,
Gayet
CH, et al:
Comparison of short-term efficacy of diltiazem and propranolol in unstable angina at rest- a randomised trial in 70 patients.
European Heart Journal
1983;
4:
691-698
Search Terms:
unstable angina and diltiazem in Cochrane
Contributor: Chris Ball and Clare Wotton,
June 2000
Reviewer: William Rhoton
Clinical Question.
| Patient |
unstable angina |
| Intervention or Exposure |
diltiazem |
| Comparison |
propranolol |
| Outcome |
continuation of angina attacks |
|
|